Comparative in Vitro Activity of Temocillin
Overview
Authors
Affiliations
The antibacterial activity of temocillin, a novel beta-lactam antibiotic, was tested against 796 clinical isolates. We also conducted a comparative study against 8 other antibiotics. Temocillin exhibited good activity against Gram-negative organisms including Escherichia coli, and the genera Proteus, Enterobacter, Serratia, Klebsiella, Citrobacter, Providencia, Salmonella, Shigella and Haemophilus: 98% of the strains were inhibited by concentrations less than or equal to 16 mg/L. The results of this in vitro study and temocillin's favourable pharmacokinetic properties suggest that temocillin is a very promising penicillin for the treatment of hospital infections caused by Gram-negative organisms.
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic.
Lupia T, De Benedetto I, Stroffolini G, Di Bella S, Mornese Pinna S, Zerbato V Antibiotics (Basel). 2022; 11(4).
PMID: 35453244 PMC: 9032032. DOI: 10.3390/antibiotics11040493.
Penicillins. A current review of their clinical pharmacology and therapeutic use.
Nathwani D, Wood M Drugs. 1993; 45(6):866-894.
PMID: 7691496 DOI: 10.2165/00003495-199345060-00002.
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Chaplin S, Sayce R, Goa K Drugs. 1989; 38(5):703-56.
PMID: 2689137 DOI: 10.2165/00003495-198938050-00003.